| 000 | 01623 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250511224402.0 | ||
| 264 | 0 | _c19900222 | |
| 008 | 199002s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00163a069 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBock, M G | |
| 245 | 0 | 0 |
_aCholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cJan 1990 |
||
| 300 |
_a450-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzodiazepines _xchemical synthesis |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aCerebral Cortex _xmetabolism |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry |
| 650 | 0 | 4 |
_aCholecystokinin _xmetabolism |
| 650 | 0 | 4 |
_aDihydromorphine _xmetabolism |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aNaloxone _xmetabolism |
| 650 | 0 | 4 |
_aPancreas _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Cholecystokinin _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Opioid _xmetabolism |
| 650 | 0 | 4 | _aReceptors, Opioid, kappa |
| 650 | 0 | 4 |
_aSincalide _xmetabolism |
| 700 | 1 | _aDiPardo, R M | |
| 700 | 1 | _aEvans, B E | |
| 700 | 1 | _aRittle, K E | |
| 700 | 1 | _aWhitter, W L | |
| 700 | 1 | _aVeber, D F | |
| 700 | 1 | _aFreidinger, R M | |
| 700 | 1 | _aChang, R S | |
| 700 | 1 | _aChen, T B | |
| 700 | 1 | _aLotti, V J | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 33 _gno. 1 _gp. 450-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00163a069 _zAvailable from publisher's website |
| 999 |
_c2159342 _d2159342 |
||